{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:42:55Z","timestamp":1792600975072,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02269-2","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T03:45:18Z","timestamp":1785037518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influence of marital status on clinical outcomes in peripheral T-cell lymphoma: a population-based analysis"],"prefix":"10.1007","volume":"26","author":[{"given":"Gengcong","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xitian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"issue":"18","key":"2269_CR1","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1182\/blood.2023021787","volume":"144","author":"J Iqbal","year":"2024","unstructured":"Iqbal J, Inghirami G, Chan WC. New insights into the biology of T-cell lymphomas. Blood. 2024;144(18):1873\u201386.","journal-title":"Blood"},{"issue":"18","key":"2269_CR2","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1182\/blood.2023021786","volume":"144","author":"L de Leval","year":"2024","unstructured":"de Leval L, Gaulard P, Dogan A. A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas. Blood. 2024;144(18):1855\u201372.","journal-title":"Blood"},{"key":"2269_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.607145","volume":"11","author":"Z Chen","year":"2021","unstructured":"Chen Z, Huang H, Li X, et al. Chemotherapy plus radiotherapy versus chemotherapy alone for patients with peripheral T-cell lymphoma Not Otherwise Specified. Front Oncol. 2021;11:607145.","journal-title":"Front Oncol"},{"key":"2269_CR4","volume":"50","author":"MC Cai","year":"2024","unstructured":"Cai MC, Cheng S, Jing HM, et al. Targeted agents plus CHOP compared with CHOP as the first-line treatment for newly diagnosed patients with peripheral T-cell lymphoma (GUIDANCE-03): an open-label, multicentre phase 2 clinical trial. Lancet Reg Health West Pac. 2024;50:101160.","journal-title":"Lancet Reg Health West Pac"},{"issue":"25","key":"2269_CR5","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1182\/blood.2023020912","volume":"144","author":"L Shea","year":"2024","unstructured":"Shea L, Mehta-Shah N. Peripheral T-cell lymphoma: are all patients high risk? Blood. 2024;144(25):2604\u201312.","journal-title":"Blood"},{"issue":"4","key":"2269_CR6","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/S2352-3026(25)00011-0","volume":"12","author":"L Malpica","year":"2025","unstructured":"Malpica L, Idrobo H, Pavlovsky A, et al. Epidemiology, clinical features, and outcomes of peripheral T-cell lymphoma in Latin America: an international, retrospective, cohort study. Lancet Haematol. 2025;12(4):e258\u201368.","journal-title":"Lancet Haematol"},{"issue":"9","key":"2269_CR7","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41591-024-03076-6","volume":"30","author":"SM Horwitz","year":"2024","unstructured":"Horwitz SM, Nirmal AJ, Rahman J, et al. Duvelisib plus romidepsin in relapsed\/refractory T cell lymphomas: a phase 1b\/2a trial. Nat Med. 2024;30(9):2517\u201327.","journal-title":"Nat Med"},{"key":"2269_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ctrv.2017.09.002","volume":"60","author":"A Broccoli","year":"2017","unstructured":"Broccoli A, Argnani L, Zinzani PL. Peripheral T-cell lymphomas: focusing on novel agents in relapsed and refractory disease. Cancer Treat Rev. 2017;60:120\u20139.","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"2269_CR9","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1093\/annonc\/mdv237","volume":"26","author":"Y Shi","year":"2015","unstructured":"Shi Y, Dong M, Hong X, et al. Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Ann Oncol. 2015;26(8):1766\u201371.","journal-title":"Ann Oncol"},{"issue":"1","key":"2269_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13045-025-01697-z","volume":"18","author":"H Hong","year":"2025","unstructured":"Hong H, Chen Z, Zhang M, et al. A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and\/or refractory peripheral T-cell lymphoma. J Hematol Oncol. 2025;18(1):50.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"2269_CR11","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/S1470-2045(24)00503-5","volume":"25","author":"PL Zinzani","year":"2024","unstructured":"Zinzani PL, Izutsu K, Mehta-Shah N, et al. Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol. 2024;25(12):1602\u201313.","journal-title":"Lancet Oncol"},{"issue":"20","key":"2269_CR12","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1158\/1078-0432.CCR-24-1194","volume":"30","author":"J Jin","year":"2024","unstructured":"Jin J, Cen H, Zhou K, et al. A phase Ib study of linperlisib in the treatment of patients with relapsed and\/or refractory peripheral T-cell lymphoma. Clin Cancer Res. 2024;30(20):4593\u2013600.","journal-title":"Clin Cancer Res"},{"key":"2269_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02171-4","author":"Z Chen","year":"2024","unstructured":"Chen Z, Huang H, Huang H, et al. Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer\/T-cell lymphoma. Leukemia. 2024. https:\/\/doi.org\/10.1038\/s41375-024-02171-4.","journal-title":"Leukemia"},{"issue":"1","key":"2269_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01560-7","volume":"17","author":"EWY Chang","year":"2024","unstructured":"Chang EWY, Tan YH, Chan JY. Novel clinical risk stratification and treatment strategies in relapsed\/refractory peripheral T-cell lymphoma. J Hematol Oncol. 2024;17(1):38.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"2269_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1470-2045(23)00589-2","volume":"25","author":"Y Song","year":"2024","unstructured":"Song Y, Malpica L, Cai Q, et al. Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study. Lancet Oncol. 2024;25(1):117\u201325.","journal-title":"Lancet Oncol"},{"issue":"2","key":"2269_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, et al. Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol. 2013;31(2):240\u20136.","journal-title":"J Clin Oncol"},{"issue":"12","key":"2269_CR17","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1182\/blood-2011-08-374371","volume":"119","author":"T Tokunaga","year":"2012","unstructured":"Tokunaga T, Shimada K, Yamamoto K, et al. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan. Blood. 2012;119(12):2837\u201343.","journal-title":"Blood"},{"issue":"1","key":"2269_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56145-8","volume":"14","author":"Q Chen","year":"2024","unstructured":"Chen Q, Zhu X, Hu Y, et al. A study on the impact of marital status on the survival status of prostate cancer patients based on propensity score matching. Sci Rep. 2024;14(1):6162.","journal-title":"Sci Rep"},{"key":"2269_CR19","doi-asserted-by":"publisher","first-page":"1136877","DOI":"10.3389\/fmed.2023.1136877","volume":"10","author":"D Zhao","year":"2023","unstructured":"Zhao D, Zhang R, Yang L, et al. The independent prognostic effect of marital status on non-small cell lung cancer patients: a population-based study. Front Med Lausanne. 2023;10:1136877.","journal-title":"Front Med Lausanne"},{"issue":"3","key":"2269_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-024-05647-z","volume":"150","author":"T Zhang","year":"2024","unstructured":"Zhang T, Wang ZT, Li Z, Yin SX, Wang X, Chen HZ. The influence of marital status at diagnosis on survival of adult patients with mantle cell lymphoma. J Cancer Res Clin Oncol. 2024;150(3):120.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"31","key":"2269_CR21","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1200\/JCO.2013.49.6489","volume":"31","author":"AA Aizer","year":"2013","unstructured":"Aizer AA, Chen MH, McCarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31(31):3869\u201376.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2269_CR22","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/cam4.5003","volume":"12","author":"K Krajc","year":"2023","unstructured":"Krajc K, Miro\u0161evi\u010d \u0160, Sajovic J, et al. Marital status and survival in cancer patients: a systematic review and meta-analysis. Cancer Med. 2023;12(2):1685\u2013708.","journal-title":"Cancer Med"},{"issue":"1","key":"2269_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/16078454.2022.2026027","volume":"27","author":"L Tang","year":"2022","unstructured":"Tang L, Pan Z, Zhang X. The effect of marital status on the survival of patients with multiple myeloma. Hematology (United States). 2022;27(1):187\u201397.","journal-title":"Hematology (United States)"},{"key":"2269_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2025.1572569","volume":"16","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Che CC, Chong MC, Zhao H, Hou Y, Zhao M. Understanding the marital self-disclosure experience during chemotherapy for gastric cancer: a qualitative study. Front Psychol. 2025;16:1572569.","journal-title":"Front Psychol"},{"key":"2269_CR25","doi-asserted-by":"crossref","unstructured":"Iris MB (2025) The relationships between marital support, partner participation, body image, and mental distress among Bedouin women with breast cancer survivors. J Psychosoc Oncol.:1\u201315.","DOI":"10.1080\/07347332.2025.2509983"},{"issue":"6","key":"2269_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07826-z","volume":"31","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Che CC, Chong MC, Zhao H, Lu Y. Effects of marital self-disclosure on marital relationship and psychological outcome for cancer patients: a systematic review. Support Care Cancer. 2023;31(6):361.","journal-title":"Support Care Cancer"},{"issue":"7","key":"2269_CR27","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1038\/s41375-025-02631-5","volume":"39","author":"Y Ito","year":"2025","unstructured":"Ito Y, Shimono J, Kawamoto K, et al. TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma. Leukemia. 2025;39(7):1723\u201334.","journal-title":"Leukemia"},{"key":"2269_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010783","author":"N Lou","year":"2025","unstructured":"Lou N, Yang M, Xie Z, et al. JAK3 (A573V) and JAK3 (M511I) mutations in peripheral T-cell lymphoma mediating resistance to anti-PD-1 therapy through the STAT3\/PD-L1 pathway. J Immunother Cancer. 2025. https:\/\/doi.org\/10.1136\/jitc-2024-010783.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2269_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13073-024-01324-5","volume":"16","author":"Z Chen","year":"2024","unstructured":"Chen Z, Huang H, Hong H, et al. Full-spectral genome analysis of natural killer\/T cell lymphoma highlights impacts of genome instability in driving its progression. Genome Med. 2024;16(1):48.","journal-title":"Genome Med"},{"issue":"2","key":"2269_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/nhs.70156","volume":"27","author":"CS Ozturk","year":"2025","unstructured":"Ozturk CS, San EG, Yildiz S. Effectiveness of psychosocial interventions on stress, anxiety, depression, and quality of life in parents of children, adolescents, and young adults with cancer: a meta-analysis of RCTs. Nurs Health Sci. 2025;27(2):e70156.","journal-title":"Nurs Health Sci"},{"key":"2269_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2024.11.048","author":"L Lin","year":"2024","unstructured":"Lin L, Lin H, Zhou R, Liu B, Liu K, Jiang R. Surviving and thriving: assessing quality of life and psychosocial interventions in mental health of head and neck cancer patients. Asian J Surg. 2024. https:\/\/doi.org\/10.1016\/j.asjsur.2024.11.048.","journal-title":"Asian J Surg"},{"issue":"4","key":"2269_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/17437199.2024.2336014","volume":"18","author":"R Telles","year":"2024","unstructured":"Telles R, Whitney BM, Froelich S, Lutgendorf SK. Mindfulness-based psychosocial interventions and psychological wellbeing in cancer survivorship: a meta-analysis. Health Psychol Rev. 2024;18(4):723\u201349.","journal-title":"Health Psychol Rev"},{"key":"2269_CR33","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 36(7):1720\u20131748.","DOI":"10.1038\/s41375-022-01620-2"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02269-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02269-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02269-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:02:41Z","timestamp":1792598561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02269-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2269"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02269-2","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"361"}}